By www.reliableresearchiq.com
Global And United States Restless Legs Syndrome Market Report & Forecast 2024-2031 Story
92
$ 4350
Restless Legs Syndrome Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Boehringer Ingelheim GmbH
UCB SA